Department of Justice January 23, 2015 – Federal Register Recent Federal Regulation Documents

Jose Raul S. Villavicencio, M.D.; Decision and Order
Document Number: 2015-01221
Type: Notice
Date: 2015-01-23
Agency: Drug Enforcement Administration, Department of Justice
Samuel Mintlow, M.D.; Decision and Order
Document Number: 2015-01219
Type: Notice
Date: 2015-01-23
Agency: Drug Enforcement Administration, Department of Justice
Privacy Act of 1974; Systems of Records
Document Number: 2015-01211
Type: Notice
Date: 2015-01-23
Agency: Department of Justice
Pursuant to the Privacy Act of 1974 (5 U.S.C. 552a), the United States Department of Justice, Office of Legal Counsel, is terminating the systems of records entitled ``Office of Legal Counsel Attorney Assignment Reports, JUSTICE/OLC-001'' and ``Office of Legal Counsel Central File, JUSTICE/OLC-003.'' The Department is eliminating the Attorney Assignment Reports system because the reports no longer exist and have been destroyed. The Department is eliminating the Central File system because the 5 x 7 card index no longer exists and the records maintained in the Central File are not retrieved by the name of individuals or by other identifying information assigned to individuals. Accordingly, the Privacy Act system of records notices last published in the Federal Register on September 4, 1985, 50 FR 35878, 35879, are removed from the Department's compilation of Privacy Act systems.
Schedules of Controlled Substances: Removal of Naloxegol From Control
Document Number: 2015-01172
Type: Rule
Date: 2015-01-23
Agency: Drug Enforcement Administration, Department of Justice
With the issuance of this final rule, the Administrator of the Drug Enforcement Administration removes naloxegol ((5[alpha],6[alpha])- 17-allyl-6-((20-hydroxy-3,6,9,12,15,18-hexaoxaicos-1-yl)oxy)- 4,5- epoxymorphinon-3,14-diol) and its salts from the schedules of the Controlled Substances Act (CSA). This scheduling action is pursuant to the CSA which requires that such actions be made on the record after opportunity for a hearing through formal rulemaking. Prior to the effective date of this rule, naloxegol was a schedule II controlled substance because it can be derived from opium alkaloids. This action removes the regulatory controls and administrative, civil, and criminal sanctions applicable to controlled substances, including those specific to schedule II controlled substances, on persons who handle (manufacture, distribute, reverse distribute, dispense, conduct research, import, export, or conduct chemical analysis) or propose to handle naloxegol.
Community Oriented Policing Services Public Meetings With Members of the Research Community, Subject-Matter Experts and the Public To Discuss Topics Relating to Policing; Correction
Document Number: 2015-01102
Type: Notice
Date: 2015-01-23
Agency: Department of Justice
The U.S. Department of Justice published a document in the Federal Register of January 15, 2015, concerning a public meeting notice to discuss topics relating to policing. The document contained times and topics that require updating.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.